{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:52:36Z","timestamp":1790211156345,"version":"4.1.0"},"reference-count":68,"publisher":"Japan Academy","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Proc. Jpn. Acad., Ser. B","Proceedings of the Japan Academy. Ser. B: Physical and Biological Sciences"],"published-print":{"date-parts":[[2020,3,11]]},"DOI":"10.2183\/pjab.96.009","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T22:07:11Z","timestamp":1583878031000},"page":"107-121","source":"Crossref","is-referenced-by-count":16,"title":["Genetic basis of myelodysplastic syndromes"],"prefix":"10.2183","volume":"96","author":[{"given":"Seishi","family":"OGAWA","sequence":"first","affiliation":[{"name":"Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"993","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Nimer, S.D. (2008) Myelodysplastic syndromes. Blood <b>111<\/b>, 4841\u20134851.","DOI":"10.1182\/blood-2007-08-078139"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tefferi, A. and Vardiman, J.W. (2009) Myelodysplastic syndromes. N. Engl. J. Med. <b>361<\/b>, 1872\u20131885.","DOI":"10.1056\/NEJMra0902908"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Corey, S.J., Minden, M.D., Barber, D.L., Kantarjian, H., Wang, J.C. and Schimmer, A.D. (2007) Myelodysplastic syndromes: The complexity of stem-cell diseases. Nat. Rev. Cancer <b>7<\/b>, 118\u2013129.","DOI":"10.1038\/nrc2047"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) List, A., Kurtin, S., Roe, D.J., Buresh, A., Mahadevan, D., Fuchs, D.  (2005) Efficacy of lenalidomide in myelodysplastic syndromes. N. Engl. J. Med. <b>352<\/b>, 549\u2013557.","DOI":"10.1056\/NEJMoa041668"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fenaux, P., Mufti, G.J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A.  (2009) Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A randomised, open-label, phase III study. Lancet Oncol. <b>10<\/b>, 223\u2013232.","DOI":"10.1016\/S1470-2045(09)70003-8"},{"key":"6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/327430a0","author":"H. Hirai","year":"1987","unstructured":"6) Hirai, H., Kobayashi, Y., Mano, H., Hagiwara, K., Maru, Y., Omine, M.  (1987) A point mutation at codon 13 of the N-<i>ras<\/i> oncogene in myelodysplastic syndrome. Nature <b>327<\/b>, 430\u2013432.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V81.11.3022.3022","author":"K. Sugimoto","year":"1993","unstructured":"7) Sugimoto, K., Hirano, N., Toyoshima, H., Chiba, S., Mano, H., Takaku, F.  (1993) Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood <b>81<\/b>, 3022\u20133026.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V93.6.1817.406k36_1817_1824","author":"M. Osato","year":"1999","unstructured":"8) Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T.  (1999) Biallelic and heterozygous point mutations in the runt domain of the <i>AML1\/PEBP2\u03b1B<\/i> gene associated with myeloblastic leukemias. Blood <b>93<\/b>, 1817\u20131824.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood.V96.9.3154","author":"Y. Imai","year":"2000","unstructured":"9) Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Takeuchi, K., Maki, K.  (2000) Mutations of the <i>AML1<\/i> gene in myelodysplastic syndrome and their functional implications in leukemogenesis. Blood <b>96<\/b>, 3154\u20133160.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2003-09-3360","author":"D.P. Steensma","year":"2004","unstructured":"10) Steensma, D.P., Higgs, D.R., Fisher, C.A. and Gibbons, R.J. (2004) Acquired somatic <i>ATRX<\/i> mutations in myelodysplastic syndrome associated with \u03b1 thalassemia (ATMDS) convey a more severe hematologic phenotype than germline <i>ATRX<\/i> mutations. Blood <b>103<\/b>, 2019\u20132026.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nannya, Y., Sanada, M., Nakazaki, K., Hosoya, N., Wang, L., Hangaishi, A.  (2005) A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. <b>65<\/b>, 6071\u20136079.","DOI":"10.1158\/0008-5472.CAN-05-0465"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yamamoto, G., Nannya, Y., Kato, M., Sanada, M., Levine, R.L., Kawamata, N.  (2007) Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am. J. Hum. Genet. <b>81<\/b>, 114\u2013126.","DOI":"10.1086\/518809"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sato-Otsubo, A., Sanada, M. and Ogawa, S. (2012) Single-nucleotide polymorphism array karyotyping in clinical practice: Where, when, and how? Semin. Oncol. <b>39<\/b>, 13\u201325.","DOI":"10.1053\/j.seminoncol.2011.11.010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Delhommeau, F., Dupont, S., Della Valle, V., James, C., Trannoy, S., Masse, A.  (2009) Mutation in <i>TET2<\/i> in myeloid cancers. N. Engl. J. Med. <b>360<\/b>, 2289\u20132301.","DOI":"10.1056\/NEJMoa0810069"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Langemeijer, S.M., Kuiper, R.P., Berends, M., Knops, R., Aslanyan, M.G., Massop, M.  (2009) Acquired mutations in <i>TET2<\/i> are common in myelodysplastic syndromes. Nat. Genet. <b>41<\/b>, 838\u2013842.","DOI":"10.1038\/ng.391"},{"key":"16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature08240","author":"M. Sanada","year":"2009","unstructured":"16) Sanada, M., Suzuki, T., Shih, L.Y., Otsu, M., Kato, M., Yamazaki, S.  (2009) Gain-of-function of mutated <i>C-CBL<\/i> tumour suppressor in myeloid neoplasms. Nature <b>460<\/b>, 904\u2013908.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ernst, T., Chase, A.J., Score, J., Hidalgo-Curtis, C.E., Bryant, C., Jones, A.V.  (2010) Inactivating mutations of the histone methyltransferase gene <i>EZH2<\/i> in myeloid disorders. Nat. Genet. <b>42<\/b>, 722\u2013726.","DOI":"10.1038\/ng.621"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nikoloski, G., Langemeijer, S.M., Kuiper, R.P., Knops, R., Massop, M., T\u00f6nnissen, E.R.  (2010) Somatic mutations of the histone methyltransferase gene <i>EZH2<\/i> in myelodysplastic syndromes. Nat. Genet. <b>42<\/b>, 665\u2013667.","DOI":"10.1038\/ng.620"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Thoennissen, N.H., Lasho, T., Thoennissen, G.B., Ogawa, S., Tefferi, A. and Koeffler, H.P. (2011) Novel <i>CUX1<\/i> missense mutation in association with 7q- at leukemic transformation of MPN. Am. J. Hematol. <b>86<\/b>, 703\u2013705.","DOI":"10.1002\/ajh.22069"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Gelsi-Boyer, V., Trouplin, V., Adelaide, J., Bonansea, J., Cervera, N., Carbuccia, N.  (2009) Mutations of polycomb-associated gene <i>ASXL1<\/i> in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br. J. Haematol. <b>145<\/b>, 788\u2013800.","DOI":"10.1111\/j.1365-2141.2009.07697.x"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21) Ley, T.J., Mardis, E.R., Ding, L., Fulton, B., McLellan, M.D., Chen, K.  (2008) DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature <b>456<\/b>, 66\u201372.","DOI":"10.1038\/nature07485"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Meyerson, M., Gabriel, S. and Getz, G. (2010) Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. <b>11<\/b>, 685\u2013696.","DOI":"10.1038\/nrg2841"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. Jr. and Kinzler, K.W. (2013) Cancer genome landscapes. Science <b>339<\/b>, 1546\u20131558.","DOI":"10.1126\/science.1235122"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Mardis, E.R., Ding, L., Dooling, D.J., Larson, D.E., McLellan, M.D., Chen, K.  (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. <b>361<\/b>, 1058\u20131066.","DOI":"10.1056\/NEJMoa0903840"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ley, T.J., Ding, L., Walter, M.J., McLellan, M.D., Lamprecht, T., Larson, D.E.  (2010) <i>DNMT3A<\/i> mutations in acute myeloid leukemia. N. Engl. J. Med. <b>363<\/b>, 2424\u20132433.","DOI":"10.1056\/NEJMoa1005143"},{"key":"26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","author":"K. Yoshida","year":"2011","unstructured":"26) Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R.  (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature <b>478<\/b>, 64\u201369.","journal-title":"?Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cell.2009.02.009","author":"M.C. Wahl","year":"2009","unstructured":"27) Wahl, M.C., Will, C.L. and Luhrmann, R. (2009) The spliceosome: Design principles of a dynamic RNP machine. Cell <b>136<\/b>, 701\u2013718.","journal-title":"Cell","ISSN":"https:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D.  (2011) Somatic <i>SF3B1<\/i> mutation in myelodysplasia with ring sideroblasts. N. Engl. J. Med. <b>365<\/b>, 1384\u20131395.","DOI":"10.1056\/NEJMoa1103283"},{"key":"29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","author":"L. Malcovati","year":"2015","unstructured":"29) Malcovati, L., Karimi, M., Papaemmanuil, E., Ambaglio, I., J\u00e4dersten, M., Jansson, M.  (2015) <i>SF3B1<\/i> mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood <b>126<\/b>, 233\u2013241.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Yoshida, K. and Ogawa, S. (2014) Splicing factor mutations and cancer. Wiley Interdiscip. Rev. RNA <b>5<\/b>, 445\u2013459.","DOI":"10.1002\/wrna.1222"},{"key":"31","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2012-01-404863","author":"M. Meggendorfer","year":"2012","unstructured":"31) Meggendorfer, M., Roller, A., Haferlach, T., Eder, C., Dicker, F., Grossmann, V.  (2012) <i>SRSF2<\/i> mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood <b>120<\/b>, 3080\u20133088.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Graubert, T.A., Shen, D., Ding, L., Okeyo-Owuor, T., Lunn, C.L., Shao, J.  (2012) Recurrent mutations in the <i>U2AF1<\/i> splicing factor in myelodysplastic syndromes. Nat. Genet. <b>44<\/b>, 53\u201357.","DOI":"10.1038\/ng.1031"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Shao, C., Yang, B., Wu, T., Huang, J., Tang, P., Zhou, Y.  (2014) Mechanisms for U2AF to define 3\u2032 splice sites and regulate alternative splicing in the human genome. Nat. Struct. Mol. Biol. <b>21<\/b>, 997\u20131005.","DOI":"10.1038\/nsmb.2906"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Darman, R.B., Seiler, M., Agrawal, A.A., Lim, K.H., Peng, S., Aird, D.  (2015) Cancer-associated SF3B1 hotspot mutations induce cryptic 3\u2032 splice site selection through use of a different branch point. Cell Rep. <b>13<\/b>, 1033\u20131045.","DOI":"10.1016\/j.celrep.2015.09.053"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Ilagan, J.O., Ramakrishnan, A., Hayes, B., Murphy, M.E., Zebari, A.S., Bradley, P.  (2015) <i>U2AF1<\/i> mutations alter splice site recognition in hematological malignancies. Genome Res. <b>25<\/b>, 14\u201326.","DOI":"10.1101\/gr.181016.114"},{"key":"36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","author":"E. Kim","year":"2015","unstructured":"36) Kim, E., Ilagan, J.O., Liang, Y., Daubner, G.M., Lee, S.C., Ramakrishnan, A.  (2015) <i>SRSF2<\/i> mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer Cell <b>27<\/b>, 617\u2013630.","journal-title":"Cancer Cell","ISSN":"https:\/\/id.crossref.org\/issn\/1535-6108","issn-type":"print"},{"key":"37","unstructured":"37) Alsafadi, S., Houy, A., Battistella, A., Popova, T., Wassef, M., Henry, E.  (2016) Cancer-associated <i>SF3B1<\/i> mutations affect alternative splicing by promoting alternative branchpoint usage. Nat. Commun. <b>7<\/b>, 10615."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Fei, D.L., Motowski, H., Chatrikhi, R., Prasad, S., Yu, J., Gao, S.  (2016) Wild-type U2AF1 antagonizes the splicing program characteristic of U2AF1-mutant tumors and is required for cell survival. PLoS Genet. <b>12<\/b>, e1006384.","DOI":"10.1371\/journal.pgen.1006384"},{"key":"39","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/onc.2016.279","author":"A.K. Kesarwani","year":"2017","unstructured":"39) Kesarwani, A.K., Ramirez, O., Gupta, A.K., Yang, X., Murthy, T., Minella, A.C.  (2017) Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3\u2032 splice sites within RNA secondary structures. Oncogene <b>36<\/b>, 1123\u20131133.","journal-title":"Oncogene","ISSN":"https:\/\/id.crossref.org\/issn\/0950-9232","issn-type":"print"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Shiozawa, Y., Malcovati, L., Galli, A., Sato-Otsubo, A., Kataoka, K., Sato, Y.  (2018) Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. Nat. Commun. <b>9<\/b>, 3649.","DOI":"10.1038\/s41467-018-06063-x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Madan, V., Kanojia, D., Li, J., Okamoto, R., Sato-Otsubo, A., Kohlmann, A.  (2015) Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome. Nat. Commun. <b>6<\/b>, 6042.","DOI":"10.1038\/ncomms7042"},{"key":"42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccell.2015.04.008","author":"C.L. Shirai","year":"2015","unstructured":"42) Shirai, C.L., Ley, J.N., White, B.S., Kim, S., Tibbitts, J., Shao, J.  (2015) Mutant U2AF1 expression alters hematopoiesis and pre-mRNA splicing in vivo. Cancer Cell <b>27<\/b>, 631\u2013643.","journal-title":"Cancer Cell","ISSN":"https:\/\/id.crossref.org\/issn\/1535-6108","issn-type":"print"},{"key":"43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2016.08.006","author":"E.A. Obeng","year":"2016","unstructured":"43) Obeng, E.A., Chappell, R.J., Seiler, M., Chen, M.C., Campagna, D.R., Schmidt, P.J.  (2016) Physiologic expression of <i>Sf3b1<\/i><sup>K700E<\/sup> causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation. Cancer Cell <b>30<\/b>, 404\u2013417.","journal-title":"Cancer Cell","ISSN":"https:\/\/id.crossref.org\/issn\/1535-6108","issn-type":"print"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Kon, A., Yamazaki, S., Nannya, Y., Kataoka, K., Ota, Y., Nakagawa, M.M.  (2018) Physiological <i>Srsf2<\/i> P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice. Blood <b>131<\/b>, 621\u2013635.","DOI":"10.1182\/blood-2017-01-762393"},{"key":"45","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/leu.2016.251","author":"A. Mupo","year":"2017","unstructured":"45) Mupo, A., Seiler, M., Sathiaseelan, V., Pance, A., Yang, Y., Agrawal, A.A.  (2017) Hemopoietic-specific <i>Sf3b1<\/i>-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts. Leukemia <b>31<\/b>, 720\u2013727.","journal-title":"Leukemia","ISSN":"https:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"46","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1038\/leu.2016.149","author":"H. Dolatshad","year":"2016","unstructured":"46) Dolatshad, H., Pellagatti, A., Liberante, F.G., Llorian, M., Repapi, E., Steeples, V.  (2016) Cryptic splicing events in the iron transporter <i>ABCB7<\/i> and other key target genes in <i>SF3B1<\/i>-mutant myelodysplastic syndromes. Leukemia <b>30<\/b>, 2322\u20132331.","journal-title":"Leukemia","ISSN":"https:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cell.2006.08.048","author":"S. Gruber","year":"2006","unstructured":"47) Gruber, S., Arumugam, P., Katou, Y., Kuglitsch, D., Helmhart, W., Shirahige, K.  (2006) Evidence that loading of cohesin onto chromosomes involves opening of its SMC hinge. Cell <b>127<\/b>, 523\u2013537.","journal-title":"Cell","ISSN":"https:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Nasmyth, K. and Haering, C.H. (2009) Cohesin: Its roles and mechanisms. Annu. Rev. Genet. <b>43<\/b>, 525\u2013558.","DOI":"10.1146\/annurev-genet-102108-134233"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Phillips-Cremins, J.E., Sauria, M.E., Sanyal, A., Gerasimova, T.I., Lajoie, B.R., Bell, J.S.  (2013) Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell <b>153<\/b>, 1281\u20131295.","DOI":"10.1016\/j.cell.2013.04.053"},{"key":"50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","author":"J.S. Welch","year":"2012","unstructured":"50) Welch, J.S., Ley, T.J., Link, D.C., Miller, C.A., Larson, D.E., Koboldt, D.C.  (2012) The origin and evolution of mutations in acute myeloid leukemia. Cell <b>150<\/b>, 264\u2013278.","journal-title":"Cell","ISSN":"https:\/\/id.crossref.org\/issn\/0092-8674","issn-type":"print"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Kon, A., Shih, L.Y., Minamino, M., Sanada, M., Shiraishi, Y., Nagata, Y.  (2013) Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. Nat. Genet. <b>45<\/b>, 1232\u20131237.","DOI":"10.1038\/ng.2731"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Solomon, D.A., Kim, T., Diaz-Martinez, L.A., Fair, J., Elkahloun, A.G., Harris, B.T.  (2011) Mutational inactivation of <i>STAG2<\/i> causes aneuploidy in human cancer. Science <b>333<\/b>, 1039\u20131043.","DOI":"10.1126\/science.1203619"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Noutsou, M., Li, J., Ling, J., Jones, J., Wang, Y., Chen, Y.  (2017) The cohesin complex is necessary for epidermal progenitor cell function through maintenance of self-renewal genes. Cell Rep. <b>20<\/b>, 3005\u20133013.","DOI":"10.1016\/j.celrep.2017.09.003"},{"key":"54","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/blood-2012-11-469619","author":"F. Damm","year":"2013","unstructured":"54) Damm, F., Chesnais, V., Nagata, Y., Yoshida, K., Scourzic, L., Okuno, Y.  (2013) <i>BCOR<\/i> and <i>BCORL1<\/i> mutations in myelodysplastic syndromes and related disorders. Blood <b>122<\/b>, 3169\u20133177.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","author":"T. Haferlach","year":"2014","unstructured":"55) Haferlach, T., Nagata, Y., Grossmann, V., Okuno, Y., Bacher, U., Nagae, G.  (2014) Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia <b>28<\/b>, 241\u2013247.","journal-title":"Leukemia","ISSN":"https:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"56","first-page":"1051","author":"D. Huang","year":"2015","unstructured":"56) Huang, D., Nagata, Y., Grossmann, V., Radivoyevitch, T., Okuno, Y., Nagae, G.  (2015) BRCC3 mutations in myeloid neoplasms. Haematologica <b>100<\/b>, 1051\u20131057.","journal-title":"Haematologica","ISSN":"https:\/\/id.crossref.org\/issn\/0390-6078","issn-type":"print"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Mori, T., Nagata, Y., Makishima, H., Sanada, M., Shiozawa, Y., Kon, A.  (2016) Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms. Leukemia <b>30<\/b>, 2270\u20132273.","DOI":"10.1038\/leu.2016.212"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Makishima, H., Yoshida, K., Nguyen, N., Przychodzen, B., Sanada, M., Okuno, Y.  (2013) Somatic <i>SETBP1<\/i> mutations in myeloid malignancies. Nat. Genet. <b>45<\/b>, 942\u2013946.","DOI":"10.1038\/ng.2696"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Sakaguchi, H., Okuno, Y., Muramatsu, H., Yoshida, K., Shiraishi, Y., Takahashi, M.  (2013) Exome sequencing identifies secondary mutations of <i>SETBP1<\/i> and <i>JAK3<\/i> in juvenile myelomonocytic leukemia. Nat. Genet. <b>45<\/b>, 937\u2013941.","DOI":"10.1038\/ng.2698"},{"key":"60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/leu.2014.144","author":"A. Kurtovic-Kozaric","year":"2015","unstructured":"60) Kurtovic-Kozaric, A., Przychodzen, B., Singh, J., Konarska, M.M., Clemente, M.J., Otrock, Z.K.  (2015) <i>PRPF8<\/i> defects cause missplicing in myeloid malignancies. Leukemia <b>29<\/b>, 126\u2013136.","journal-title":"Leukemia","ISSN":"https:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"61","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/leu.2013.179","author":"I. Gomez-Segui","year":"2013","unstructured":"61) Gomez-Segui, I., Makishima, H., Jerez, A., Yoshida, K., Przychodzen, B., Miyano, S.  (2013) Novel recurrent mutations in the RAS-like GTP-binding gene <i>RIT1<\/i> in myeloid malignancies. Leukemia <b>27<\/b>, 1943\u20131946.","journal-title":"Leukemia","ISSN":"https:\/\/id.crossref.org\/issn\/0887-6924","issn-type":"print"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V.I., Paschka, P., Roberts, N.D.  (2016) Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med. <b>374<\/b>, 2209\u20132221.","DOI":"10.1056\/NEJMoa1516192"},{"key":"63","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","author":"S. Ogawa","year":"2019","unstructured":"63) Ogawa, S. (2019) Genetics of MDS. Blood <b>133<\/b>, 1049\u20131059.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"64","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","author":"E. Papaemmanuil","year":"2013","unstructured":"64) Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P.  (2013) Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood <b>122<\/b>, 3616\u20133627.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Makishima, H., Yoshizato, T., Yoshida, K., Sekeres, M.A., Radivoyevitch, T., Suzuki, H.  (2017) Dynamics of clonal evolution in myelodysplastic syndromes. Nat. Genet. <b>49<\/b>, 204\u2013212.","DOI":"10.1038\/ng.3742"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) da Silva-Coelho, P., Kroeze, L.I., Yoshida, K., Koorenhof-Scheele, T.N., Knops, R., van de Locht, L.T.  (2017) Clonal evolution in myelodysplastic syndromes. Nat. Commun. <b>8<\/b>, 15099.","DOI":"10.1038\/ncomms15099"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Chen, J., Kao, Y., Sun, D., Todorova, T., Reynolds, D., Narayanagari, S.-R.  (2019) Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level. Nat. Med. <b>25<\/b>, 103\u2013110.","DOI":"10.1038\/s41591-018-0267-4"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Bejar, R., Stevenson, K., Abdel-Wahab, O., Galili, N., Nilsson, B., Garcia-Manero, G.  (2011) Clinical effect of point mutations in myelodysplastic syndromes. N. Engl. J. Med. <b>364<\/b>, 2496\u20132506.","DOI":"10.1056\/NEJMoa1013343"}],"container-title":["Proceedings of the Japan Academy, Series B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/pjab\/96\/3\/96_PJA9603B-03\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T03:34:42Z","timestamp":1584156882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/pjab\/96\/3\/96_PJA9603B-03\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2183\/pjab.96.009","relation":{},"ISSN":["0386-2208","1349-2896"],"issn-type":[{"value":"0386-2208","type":"print"},{"value":"1349-2896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,11]]}}}